X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
index medicus (10) 10
female (9) 9
male (9) 9
cardiovascular (8) 8
aged (7) 7
animals (7) 7
middle aged (7) 7
abridged index medicus (6) 6
care and treatment (6) 6
heart failure (6) 6
hyperkalemia (6) 6
angiotensin (5) 5
biochemistry & molecular biology (5) 5
chronic kidney disease (5) 5
chronic kidney failure (5) 5
double-blind method (5) 5
expression (5) 5
hypertension (5) 5
kidney diseases (5) 5
molecular sequence data (5) 5
safety (5) 5
amino acid sequence (4) 4
cardiac patients (4) 4
drosophila - genetics (4) 4
hyperkalemia - drug therapy (4) 4
internal medicine (4) 4
medicine, general & internal (4) 4
nitric oxide (4) 4
nitric oxide synthase - genetics (4) 4
potassium (4) 4
potassium - blood (4) 4
renal insufficiency, chronic - complications (4) 4
acidosis (3) 3
aldosterone (3) 3
angiotensin-converting enzyme inhibitors - adverse effects (3) 3
angiotensin-converting enzyme inhibitors - therapeutic use (3) 3
cell division (3) 3
corticosteroids (3) 3
diabetes (3) 3
dosage and administration (3) 3
guidelines (3) 3
hydrochloric acid (3) 3
kidneys (3) 3
management (3) 3
metabolic acidosis (3) 3
mice (3) 3
mice, knockout (3) 3
mineralocorticoid receptor antagonists - therapeutic use (3) 3
mortality (3) 3
nitric oxide - pharmacology (3) 3
nitric oxide synthase - antagonists & inhibitors (3) 3
nitric oxide synthase - metabolism (3) 3
patients (3) 3
polymers - adverse effects (3) 3
polymers - therapeutic use (3) 3
renal insufficiency, chronic - drug therapy (3) 3
renin-angiotensin system - drug effects (3) 3
risk factors (3) 3
sodium (3) 3
steroids (3) 3
urology & nephrology (3) 3
acetates - administration & dosage (2) 2
activation (2) 2
administration, oral (2) 2
adult (2) 2
adult neurogenesis (2) 2
alternative splicing (2) 2
analysis (2) 2
angiotensin receptor antagonists - therapeutic use (2) 2
animals, genetically modified (2) 2
atherosclerosis (2) 2
bicarbonates (2) 2
blotting, northern (2) 2
brain (2) 2
carbonates (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular disease (2) 2
catabolism (2) 2
cell biology (2) 2
cell-proliferation (2) 2
cells, cultured (2) 2
cholesterol (2) 2
ckd (2) 2
clinical trials (2) 2
cloning, molecular (2) 2
constipation (2) 2
coronary disease - blood (2) 2
coronary disease - drug therapy (2) 2
coronary heart disease (2) 2
critical care (2) 2
diabetic nephropathies (2) 2
disease control (2) 2
dose-response relationship, drug (2) 2
drosophila - growth & development (2) 2
drosophila development (2) 2
drug administration schedule (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
enzyme inhibitors - pharmacology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 3, pp. 211 - 221
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 14, pp. 1079 - 1088
Objectives The purpose of this study was to investigate the effects of varespladib on cardiovascular biomarkers in acute coronary syndrome patients. Background... 
Cardiovascular | Internal Medicine | varespladib | inflammation | secretory phospholipase A2 | acute coronary syndromes | low-density lipoprotein | C-REACTIVE PROTEIN | IIA | CARDIAC & CARDIOVASCULAR SYSTEMS | LOW-DENSITY-LIPOPROTEIN | ATHEROSCLEROSIS | ARACHIDONIC-ACID | PROGNOSTIC VALUE | PLASMA-LEVELS | LDL | secretory phospholipase A | EXPRESSION | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Reference Values | Cholesterol, LDL - analysis | Indoles - administration & dosage | Dose-Response Relationship, Drug | Phospholipases A2, Secretory - drug effects | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Female | C-Reactive Protein - drug effects | C-Reactive Protein - analysis | Drug Therapy, Combination | Double-Blind Method | Drug Administration Schedule | Phospholipases A2, Secretory - blood | Cholesterol, LDL - drug effects | Logistic Models | Treatment Outcome | Biomarkers - blood | Acute Coronary Syndrome - drug therapy | Atorvastatin Calcium | Acetates - administration & dosage | Acute Coronary Syndrome - diagnosis | Aged | Medical colleges | C-reactive protein | Analysis | Low density lipoproteins | Cardiac patients | Phospholipases | Biological markers | Heart attack | Cholesterol | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Angina pectoris
Journal Article
Kidney International, ISSN 0085-2538, 12/2015, Volume 88, Issue 6, pp. 1427 - 1433
Patients with chronic kidney disease (CKD) have a high risk of hyperkalemia, which increases mortality and can lead to renin–angiotensin–aldosterone system... 
chronic kidney disease | potassium binder | renin–angiotensin–aldosterone system inhibitor | hyperkalemia | MANAGEMENT | BINDER | SAFETY | HEART-FAILURE | PREVENTION | RESONIUM | renin-angiotensin-aldosterone system inhibitor | UROLOGY & NEPHROLOGY | SODIUM POLYSTYRENE SULFONATE | INHIBITORS | INTESTINAL NECROSIS | Clinical Trial
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 10, pp. A855 - A855
  Methods: Multicenter, open-label trial of 304 pts with CKD, DM, HTN and serum K+ (s-K+) >5.0 mEq/L; pts randomized to patiromer starting doses by baseline... 
Cardiovascular | Internal Medicine | Heart failure | Corticosteroids | Chronic kidney failure | Cardiac patients | Angiotensin | Steroids | Medical treatment
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A14271 - A14271
IntroductionEmerging treatments for hyperkalemia (HK) may have favorable effects on the risk:benefit ratio for pts with HTN and diabetic kidney disease (DKD)... 
Journal Article
Kidney International, ISSN 0085-2538, 09/2016, Volume 90, Issue 3, pp. 696 - 704
Journal Article
Nephrology Dialysis Transplantation, ISSN 0931-0509, 05/2015, Volume 30, Issue suppl_3, pp. iii51 - iii52
Journal Article